Home/Filings/4/0001209191-17-005571
4//SEC Filing

Kura Oncology, Inc. 4

Accession 0001209191-17-005571

$KURACIK 0001422143operating

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 5:34 PM ET

Size

5.4 KB

Accession

0001209191-17-005571

Insider Transaction Report

Form 4
Period: 2017-01-23
REN PINGDA
SVP, Chemistry
Transactions
  • Award

    Option to purchase common stock

    2017-01-23+55,00055,000 total
    Exercise: $6.15Exp: 2027-01-22Common Stock (55,000 underlying)
Footnotes (1)
  • [F1]This option vests in 48 equal monthly installments commencing on the grant date.

Issuer

Kura Oncology, Inc.

CIK 0001422143

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001422143

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 5:34 PM ET
Size
5.4 KB